What is the Org number of ANTIGRADE AS?

ANTIGRADE AS is registered with Brønnøysundsregistrene under Org 921760477.

What is the revenue of ANTIGRADE AS?

ANTIGRADE AS reported revenue of NOK 354K in 2024.

ANTIGRADE AS employs 4 people as of the latest annual report.

Sjur Andreas Velsvik is the CEO of ANTIGRADE AS, in role since 2024.

Jostein Svendsen chairs the board of ANTIGRADE AS, in role since 2024.

ANTIGRADE AS's registered address is Olaf Helsets Vei 5, 0694 Oslo.

ASActive

Org 921760477Olaf Helsets Vei 5, 0694 OsloNon-specialised wholesale trade· NACE 4690Est. 2018 · 7 years old4 employees

Actively employed in the business

Name	Role	Member since
Current (1)
SA Sjur Andreas Velsvik Chief Executive Officer	Chief Executive Officer	2024
Former (2)
KU Kjetil Ulving-Tufte Chief Executive Officer	Chief Executive Officer	2021 – 2021
CH Charles Høstlund Chief Executive Officer	Chief Executive Officer	2021 – 2024

Non-executive oversight

Name	Role	Member since
Current (3)
BM Bjarne Marvin Hadland Board of Directors	Board of Directors	2024
JS Jostein Svendsen Chairman	Chairman	2024
RI Ronny Ingvar Breivik Board of Directors	Board of Directors	2024
Former (4)
LT Lars Tormodsgard Board of Directors	Board of Directors	2021 – 2024
TW Truls William Eriksen Board of Directors	Board of Directors	2021 – 2023
BI Bjørnar Iversen Chairman	Chairman	2019 – 2021
EV Erik Volden Chairman	Chairman	2021 – 2024

As of last annual report

Shareholder	Type	Ownership	Votes	Since
Aland Holding As	Company	18.75%	18.75%	2025
Amarine Holding As	Company	18.75%	18.75%	2025
Samvel Holding As	Company	13.69%	13.69%	2025
Samvel As	Company	7.3%	7.3%	2025
Aeonic As	Company	5.55%	5.55%	2025
S22 Holding As	Company	5%	5%	2025
T42 Holding As	Company	5%	5%	2025
Kello As	Company	2.96%	2.96%	2025
Entero As	Company	2.13%	2.13%	2025
Sønstebø Gruppen As	Company	1.87%	1.87%	2025
Daimyo Invest As	Company	1.68%	1.68%	2025
Union Bancaire Privee, Ubp Sa	Company	1.62%	1.62%	2025
Sten Stenersen	Individual	1.47%	1.47%	2025

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.